An imbalance between proliferation and differentiation underlies the development of microRNA-defective pineoblastoma.

in Genes & development by Claudette R Fraire, Kavita Desai, Indumathy Jagadeeswaran, Uma A Obalapuram, Lindsay K Mendyka, Veena Rajaram, Teja Sebastian, Yemin Wang, Kenan Onel, Jeon Lee, Stephen X Skapek, Kenneth S Chen

TLDR

  • The study utilized a mouse model to investigate the role of microRNA processing in the development of pineoblastoma, a brain tumor. The study found that inhibiting downstream drivers of proliferation may be a therapeutic strategy for tumors driven by loss of microRNA processing.

Abstract

Mutations in the microRNA processing genesanddrive several cancers that resemble embryonic progenitors. To understand how microRNAs regulate tumorigenesis, we ablatedorin the developing pineal gland to emulate the pathogenesis of pineoblastoma, a brain tumor that resembles undifferentiated precursors of the pineal gland. Accordingly, these mice develop pineal tumors marked by loss of microRNAs, particularly the let-7/miR-98-5p family, and derepression of microRNA target genes. Pineal tumors driven by loss oformimic tumors driven byloss, as they exhibit upregulation of S-phase genes and homeobox transcription factors that regulate pineal development. Blocking proliferation of these tumors facilitates expression of pinealocyte maturation markers, with a concomitant reduction in embryonic markers. Select embryonic markers remain elevated, however, as the microRNAs that normally repress these target genes remain absent. One such microRNA target gene is the oncofetal transcription factor, which regulates expression of progrowth genes, and inhibiting their signaling impairs tumor growth. Thus, we demonstrate that tumors driven by loss of microRNA processing may be therapeutically targeted by inhibiting downstream drivers of proliferation.

Overview

  • The study aims to understand how microRNAs regulate tumorigenesis by ablating the microRNA processing genes in the developing pineal gland to emulate pineoblastoma, a brain tumor.
  • The mice develop pineal tumors with loss of microRNAs, particularly the let-7/miR-98-5p family, and derepression of microRNA target genes.
  • The study explores the potential therapeutic targets for tumors driven by loss of microRNA processing by inhibiting downstream drivers of proliferation.

Comparative Analysis & Findings

  • The study found that tumors driven by loss oformimic tumors driven byloss, as they exhibit upregulation of S-phase genes and homeobox transcription factors that regulate pineal development.
  • Blocking proliferation of these tumors facilitates expression of pinealocyte maturation markers, with a concomitant reduction in embryonic markers.
  • However, select embryonic markers remain elevated, as the microRNAs that normally repress these target genes remain absent.

Implications and Future Directions

  • The study demonstrates that tumors driven by loss of microRNA processing may be therapeutically targeted by inhibiting downstream drivers of proliferation.
  • Further research is needed to explore the potential of inhibiting oncofetal transcription factors as a therapeutic strategy for tumors driven by loss of microRNA processing.
  • The study highlights the importance of understanding the role of microRNAs in tumorigenesis to identify novel therapeutic targets for cancer treatment.